Zobrazeno 1 - 10
of 277
pro vyhledávání: '"Daniel and Haller"'
Autor:
Claire Gallois, Qian Shi, Jeffrey P. Meyers, Timothy Iveson, Steven R. Alberts, Aimery de Gramont, Alberto F. Sobrero, Daniel G. Haller, Eiji Oki, Anthony Frank Shields, Richard M. Goldberg, Rachel Kerr, Sara Lonardi, Greg Yothers, Caroline Kelly, Ioannis Boukovinas, Roberto Labianca, Frank A. Sinicrope, Ioannis Souglakos, Takayuki Yoshino, Jeffrey A. Meyerhardt, Thierry André, Demetris Papamichael, Julien Taieb
Publikováno v:
Journal of Clinical Oncology. 41:803-815
PURPOSE Oxaliplatin-based adjuvant chemotherapy in patients with stage III colon cancer (CC) for 6 months remains a standard in high-risk stage III patients. Data are lacking as to whether early discontinuation of all treatment (ETD) or early discont
Autor:
Sean M. Engels, Pratik Kamat, G. Stavros Pafilis, Yukang Li, Anshika Agrawal, Daniel J. Haller, Jude M. Phillip, Lydia M. Contreras
Publikováno v:
bioRxiv
Particulate matter (PM) is a ubiquitous component of indoor and outdoor air pollution that is epidemiologically linked to many human pulmonary diseases. PM has many emission sources, making it challenging to understand the biological effects of expos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2acd98a6a9252a7ab6d13b76bd34cedf
https://europepmc.org/articles/PMC10245696/
https://europepmc.org/articles/PMC10245696/
Autor:
Christopher Tweleves, Hans-Joachim Schmoll, Silvia Marsoni, Naohiro Tomita, Qian Shi, Richard M. Goldberg, Michael J. O'Connell, Carmen J. Allegra, Daniel G. Haller, Greg Yothers, Jean-François Seitz, Amit Mahipal, Thierry André, Thomas J. George, Takayuki Yoshino, Julien Taieb, Takeharu Yamanaka, Frank A. Sinicrope, Leonard B. Saltz, Charles D. Blanke, Jack Fiskum, Rachel Kerr, Charles Erlichman, Hiral D. Parekh, Norman Wolmark, Aimery de Gramont, Jesse G. Dixon, Eric Van Cutsem, Sotaro Sadahiro, Zhaohui Jin
Publikováno v:
J Natl Cancer Inst
Background Colon cancer (CC) incidence in young adults (age 20-49 years), termed early-onset CC (EO-CC), is increasing. Methods Individual patient data on 35 713 subjects with stage III colon cancer from 25 randomized studies in the Adjuvant Colon Ca
Autor:
Hans-Joachim Schmoll, Aimery de Gramont, Norman Wolmark, Greg Yothers, Einat Shacham-Shmueli, Ofer Margalit, Qian Shi, André Thierry, Daniel G. Haller, Manel Rakez, Ben Boursi
Publikováno v:
Clinical Colorectal Cancer. 20:130-136
Background The International Duration Evaluation of Adjuvant Chemotherapy (IDEA) pooled analysis compared 3 to 6 months of adjuvant chemotherapy for stage III colon cancer. Patients were classified into low risk and high risk, suggesting low-risk pat
Autor:
Steven R. Alberts, Sara Lonardi, Julien Taieb, Greg Yothers, Rachel Kerr, Norman Wolmark, Takayuki Yoshino, Charles Erlichman, Thierry André, Daniel G. Haller, Alberto Zaniboni, Aimery de Gramont, Jean Francois Seitz, Carmen J. Allegra, Axel Grothey, Romain Cohen, Qian Shi, Frank A. Sinicrope, Richard M. Goldberg, Jack Fiskum, Michael J. O'Connell
Publikováno v:
J Clin Oncol
PURPOSE: In patients with stage III colon cancer (CC) whose tumors demonstrate microsatellite instability (MSI), the efficacy of adjuvant fluoropyrimidine (FP) with or without oxaliplatin has not been clearly demonstrated and the prognostic value of
Autor:
Timothy J. Price, Amitesh Roy, Marc Peeters, Nick Pavlakis, Niall C. Tebbutt, Jeremy D. Shapiro, Daniel G. Haller, Matthew Burge, Christos S. Karapetis, Ian Chau, Eva Segelov, David K. Lau
Publikováno v:
Expert review of anticancer therapy
Introduction: Outcomes in metastatic colorectal cancer are improving, due to the tailoring of therapy enabled by better understanding of clinical behavior according to molecular subtype. Areas covered: A review of the literature and recent conference
Autor:
Harvey J. Mamon, Jai N. Patel, Georg A. Bjarnason, Donna Niedzwiecki, Jasmine A. Luzum, Charles S. Fuchs, Daniel G. Haller, Kouros Owzar, Chen Jiang, Flora Mulkey, Tomislav Dragovich, Steven R. Alberts, Mark J. Ratain, C. Willet, Peter C. Enzinger, Howard L. McLeod
Publikováno v:
Pharmacogenet Genomics
There is a lack of pharmacogenetic predictors of outcome in gastric cancer patients. The aim of this study was to assess previously identified candidate genes associated with 5-fluorouracil (5-FU), cisplatin, or epirubicin toxicity or response in a c
Publikováno v:
DeckerMed Medicine.
According to 2009 estimates from the American Cancer Society, cancers originating in the gastrointestinal tract rank second in both incidence and cancer-related deaths. One in four deaths in the United States is caused by cancer, with 25% of cancer-r
Autor:
Steven R. Alberts, Eric VanCutsem, Thierry André, Norman Wolmark, Carmen J. Allegra, Rachel Kerr, Thomas J. George, Greg Yothers, Julien Taieb, Axel Grothey, Silvia Marsoni, Qian Shi, Richard M. Goldberg, Charles D. Blanke, Leonard B. Saltz, Aimery de Gramont, Chris Twelves, Daniel G. Haller, Jean Francois Seitz, Anna Dorothea Wagner, Jesse G. Dixon, Michael J. O'Connell, Edoardo Francini
Publikováno v:
J Natl Cancer Inst
Background Adjuvant chemotherapy is a standard treatment option for patients with stage III and high-risk stage II colon cancer. Sex is one of several factors responsible for the wide inter-patient variability in drug responses. Amalgamated data on t
Publikováno v:
Nucleic Acids Research. 50:e58-e58
Directed evolution is a powerful method for engineering biology in the absence of detailed sequence-function relationships. To enable directed evolution of complex phenotypes encoded by multigene pathways, we require large library sizes for DNA seque